CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 75 enrolled
Drug / intervention
Dronabinol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01755091
NCT01755091Phase 2Completed
CompareCT.gov

Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial

University of Illinois at Chicago·interventional·Posted Dec 21, 2012·Updated Jul 29, 2021

In Brief

A Phase 2 clinical trial evaluating Dronabinol and Placebo (for Dronabinol) for Sleep Apnea, Obstructive. Completed, enrolled 75 participants across 2 sites.

Detailed Summary

This is a proof of concept study to determine the safety and efficacy of dronabinol for the treatment of obstructive sleep apnea syndrome (OSA).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Apnea, Obstructive
CountriesUnited States
CollaboratorsNorthwestern University, University of Chicago, Hektoen Institute for Medical Research, National Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 21, 2012
Enrollment StartFeb 1, 2013
Primary CompletionJun 1, 2016
Study CompletionDec 31, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.5 years ago

Interventions

Dronabinoldrug

Placebo (for Dronabinol)drug